Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder

详细信息    查看全文

• 作者：Jerry Polesel ; Cristina Bosetti ; Matteo di Maso…
• 关键词：Tobacco smoking ; Transitional cell carcinoma ; Papillary ; Bladder ; Risk
• 刊名：Cancer Causes and Control
• 出版年：2014
• 出版时间：September 2014
• 年：2014
• 卷：25
• 期：9
• 页码：1151-1158
• 全文大小：232 KB
• 参考文献：1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer: Lyon, France. Available from: http://globocan.iarc.fr, accessed on 13/01/2014
  2. Silverman BT, Devesa SS, Moore LE, Rothman N (2006) Bladder cancer. Cancer epidemiology and prevention, 3rd edn. Oxford Univ Press, New York
  3. Eble JN, Sauter G, Epstein JI, Sesterhenn IAD (eds) (2004) World health organization classification of tumours. Tumours of the urinary system and genital male organs. IARC Press, Lyon
  4. IARC (2004) IARC monographs on the evaluation of carcinogenic risks to Humans, Vol 83. Tobacco smoke and involuntary smoking. IARC Sci Publ. Lyon: IARC
  5. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306:737-45 CrossRef
  6. Brennan P, Bogilot O, Cordier S et al (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer 86:289-94 CrossRef
  7. Samanic C, Kogevinas M, Dosemici M et al (2006) Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomark Prev 15:1348-354 CrossRef
  8. Baris D, Karagas MR, Verrill C et al (2009) A case–control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101:1553-561 CrossRef
  9. Hinotsu S, Akaza H, Miki T et al (2009) Bladder cancer develops 6?years earlier in current smokers: analysis of bladder cancer registry data by the cancer registration committee of the Japanese urological association. Int J Urol 16:64-9 CrossRef
  10. Pietzak EJ, Malkowicz (2014) Does quantification of smoking history correlate with initial bladder tumor grade and stage? Curr Urol Rep. 15:416. doi: 10.1007/s11934-014-0416-3
  11. Jiang X, Castelao JE, Yuan JM et al (2012) Cigarette smoking and subtype of bladder cancer. Int J Cancer 130:896-01 CrossRef
  12. Sturgeon SR, Hartge P, Silverman DT et al (1994) Association between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 5:218-25 CrossRef
  13. Polesel J, Gheit T, Talamini R et al (2012) Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 106:222-26 CrossRef
  14. D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D (1996) Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology 7:312-15 CrossRef
  15. Breslow NE, Day NE (1980) Statistical methods in cancer research, vol 1. The analysis of case–control studies. IARC Sci Publ No. 32. IARC: Lyon
  16. Benichou J (1991) Methods of adjustment for estimating the attributable risk in case–control studies: a review. Stat Med 10:1753-773 CrossRef
  17. Bjerregaard BK, Raaschou-Nielsen O, S?rensen M et al (2006) Tobacco smoke and bladder cancer—in the European prospective investigation into cancer and nutrition. Int J Cancer 119:2412-416 CrossRef
  18. Augustine A, Hebert JR, Kabat GC, Wynder EL (1988) Bladder cancer in relation to cigarette smoking. Cancer Res 48:4405-408
  19. Hartge P, Silverman DT, Schairer C, Hoover RN (1993) Smoking and bladder cancer risk in blacks and whites in the United States. Cancer Cause Control 4:391-94 CrossRef
  20. Chiu BCH, Lynch CF, Cerhan JR, Cantor KP (2001) Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancer in Iowa. Ann Epidemiol 11:28-7 CrossRef
  21. Castelao JE, Yuan JM, Skipper PL et al (2001) Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93:538-45 CrossRef
  22. Puente D, Hartge P, Greiser E et al (2006) A pooled analysis of bladder cancer case–control studies evaluating smoking in men and women. Cancer Causes Control 17:71-9 CrossRef
  23. Lubin JH, Alavanja MC, Caporaso N et al (2007) Cigarette smoking and cancer risk: modelling total exposure and intensity. Am J Epidemiol 166:479-89 CrossRef
  24. Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3:461-69 CrossRef
  25. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733-44 CrossRef
  26. Sanderson S, Salanti G, Higgins J (2007) Joint effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis. A literature-based systemic huge review and evidence synthesis. Am J Epidemiol 166:741-51 CrossRef
  27. Stern MC, Lin J, Figueroa JD et al (2009) Polymorphisms in DNA repair gene, smoking, and bladder cancer risk: findings from the International Consortium of Bladder Cancer. Cancer Res 69:6857-864 CrossRef
  
• 作者单位：Jerry Polesel (1)
  Cristina Bosetti (2)
  Matteo di Maso (1)
  Maurizio Montella (3)
  Massimo Libra (4)
  Antonio Garbeglio (5)
  Antonella Zucchetto (1) (6)
  Federica Turati (2)
  Renato Talamini (1)
  Carlo La Vecchia (6)
  Diego Serraino (1)
  
  1. Unit of Epidemiology and Biostatistics, IRCCS - CRO Aviano National Cancer Institute, Via F. Gallini 2, 33081, Aviano, PN, Italy
  2. Department of Epidemiology, IRCCS - The Mario Negri Institute for Pharmacological Research, Milan, Italy
  3. Unit of Epidemiology, IRCCS - Istituto Tumori “Fondazione Pascale- Naples, Italy
  4. Department of Biomedical Sciences, Università di Catania, Catania, Italy
  5. Urology Unit, Azienda Ospedaliera S. Maria Degli Angeli, Pordenone, Italy
  6. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
  
• ISSN：1573-7225

文摘

Purpose To evaluate the impact of tobacco smoking on specific histological subtypes of transitional cell carcinoma of the bladder (TCC). Methods Between 2003 and 2009, we conducted a hospital-based case-control study in Italy, enrolling 531 incident TCC cases and 524 cancer-free matched patients. Odds ratios (OR) and corresponding 95% confidence intervals (CI) were estimated through multiple logistic regression models. Results Compared to never smokers, TCC risk was threefold higher in former smokers (95% CI 2.07-.18) and more than sixfold higher in current smokers (95% CI 4.54-.85). TCC risk steadily increased with increasing intensity (OR for ?5 cigarettes/day 8.75; 95% CI 3.40-2.55) and duration of smoking (OR for ?0?years 5.46; 95% CI 2.60-1.49). No heterogeneity emerged between papillary and non-papillary TCCs for smoking intensity and duration, but the risk for those who had smoked for ?0?years was twice for non-papillary TCC (OR 10.88) compared with papillary one (OR 4.76). Among current smokers, the risk for a 10-year increase in duration grew across strata of intensity (p-trend?=?0.046). Conversely, the risk for a 5-cigarette/day increase in smoking intensity was quite steady across strata of duration (p-trend?=?0.18). Conclusions Study results suggested that duration of smoking outweighs intensity in determining TCC risk, with limited differences across histological subtypes. Elimination of tobacco smoking may prevent about 65?% of TCCs.